Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carrier Proteins | 15 | 2024 | 681 | 3.760 |
Why?
|
| Sarcomeres | 10 | 2024 | 27 | 3.680 |
Why?
|
| Cardiomyopathy, Hypertrophic | 5 | 2023 | 42 | 2.770 |
Why?
|
| Myocytes, Cardiac | 9 | 2024 | 314 | 2.770 |
Why?
|
| Myocardial Contraction | 9 | 2024 | 252 | 2.010 |
Why?
|
| Myofibrils | 3 | 2023 | 23 | 1.660 |
Why?
|
| Cardiomyopathy, Dilated | 3 | 2023 | 101 | 1.530 |
Why?
|
| Arrhythmias, Cardiac | 4 | 2024 | 199 | 1.510 |
Why?
|
| Heart Atria | 4 | 2024 | 282 | 1.320 |
Why?
|
| Cytoskeletal Proteins | 2 | 2022 | 228 | 1.280 |
Why?
|
| Proteolysis | 3 | 2024 | 110 | 1.080 |
Why?
|
| Myocardium | 8 | 2023 | 571 | 0.960 |
Why?
|
| Muscle Proteins | 2 | 2024 | 133 | 0.960 |
Why?
|
| Cardiomyopathies | 4 | 2024 | 264 | 0.930 |
Why?
|
| Calcium | 6 | 2022 | 1175 | 0.920 |
Why?
|
| Calpain | 2 | 2024 | 113 | 0.850 |
Why?
|
| Cardiac Conduction System Disease | 1 | 2022 | 7 | 0.830 |
Why?
|
| Dysferlin | 2 | 2021 | 14 | 0.820 |
Why?
|
| Excitation Contraction Coupling | 1 | 2021 | 8 | 0.780 |
Why?
|
| Haploinsufficiency | 2 | 2023 | 65 | 0.680 |
Why?
|
| Atrial Fibrillation | 1 | 2024 | 358 | 0.670 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2019 | 58 | 0.630 |
Why?
|
| Cardiotonic Agents | 1 | 2019 | 89 | 0.630 |
Why?
|
| Induced Pluripotent Stem Cells | 3 | 2024 | 117 | 0.610 |
Why?
|
| Animals | 29 | 2024 | 27371 | 0.600 |
Why?
|
| Medical Laboratory Personnel | 1 | 2017 | 4 | 0.600 |
Why?
|
| Narration | 1 | 2017 | 17 | 0.600 |
Why?
|
| Membrane Proteins | 2 | 2021 | 1224 | 0.560 |
Why?
|
| Mutation | 10 | 2024 | 4143 | 0.550 |
Why?
|
| Mentors | 1 | 2017 | 87 | 0.550 |
Why?
|
| Muscle, Skeletal | 6 | 2022 | 468 | 0.500 |
Why?
|
| Mice | 18 | 2023 | 11761 | 0.490 |
Why?
|
| Disease Models, Animal | 10 | 2024 | 2366 | 0.450 |
Why?
|
| Myosins | 3 | 2023 | 92 | 0.440 |
Why?
|
| Biomedical Research | 1 | 2017 | 398 | 0.430 |
Why?
|
| Cell Membrane | 3 | 2021 | 672 | 0.400 |
Why?
|
| Phosphorylation | 7 | 2019 | 1132 | 0.390 |
Why?
|
| Myocardial Infarction | 4 | 2019 | 374 | 0.390 |
Why?
|
| Muscular Dystrophies | 2 | 2021 | 55 | 0.380 |
Why?
|
| Atrial Function | 2 | 2023 | 19 | 0.380 |
Why?
|
| Disease Progression | 1 | 2014 | 1489 | 0.350 |
Why?
|
| Heterozygote | 3 | 2017 | 373 | 0.350 |
Why?
|
| Annexin A6 | 3 | 2019 | 10 | 0.340 |
Why?
|
| Muscular Dystrophy, Animal | 3 | 2019 | 21 | 0.340 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 2 | 2019 | 15 | 0.300 |
Why?
|
| Heart Ventricles | 3 | 2017 | 779 | 0.290 |
Why?
|
| Glucocorticoids | 2 | 2022 | 358 | 0.290 |
Why?
|
| Heart Failure | 4 | 2020 | 1185 | 0.270 |
Why?
|
| Mice, 129 Strain | 3 | 2021 | 56 | 0.260 |
Why?
|
| Ventricular Remodeling | 2 | 2019 | 106 | 0.260 |
Why?
|
| Mice, Transgenic | 6 | 2019 | 1574 | 0.260 |
Why?
|
| Humans | 19 | 2024 | 89357 | 0.250 |
Why?
|
| Protein Isoforms | 2 | 2023 | 275 | 0.240 |
Why?
|
| Filamins | 1 | 2024 | 22 | 0.240 |
Why?
|
| Proteostasis | 1 | 2024 | 12 | 0.240 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2023 | 2340 | 0.230 |
Why?
|
| Muscular Dystrophy, Duchenne | 2 | 2021 | 34 | 0.220 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2019 | 329 | 0.220 |
Why?
|
| Dogs | 1 | 2024 | 704 | 0.220 |
Why?
|
| Muscle Fibers, Skeletal | 3 | 2019 | 49 | 0.220 |
Why?
|
| Male | 15 | 2024 | 42411 | 0.210 |
Why?
|
| Caffeine | 1 | 2023 | 83 | 0.210 |
Why?
|
| Contactins | 1 | 2022 | 2 | 0.210 |
Why?
|
| Purkinje Fibers | 1 | 2022 | 27 | 0.210 |
Why?
|
| Tachycardia | 1 | 2022 | 37 | 0.200 |
Why?
|
| Protein Binding | 2 | 2023 | 1488 | 0.200 |
Why?
|
| Membrane Fusion | 1 | 2021 | 37 | 0.190 |
Why?
|
| Prednisone | 2 | 2022 | 259 | 0.190 |
Why?
|
| Calcium-Binding Proteins | 1 | 2021 | 121 | 0.190 |
Why?
|
| Phenotype | 3 | 2017 | 2440 | 0.180 |
Why?
|
| Sarcolemma | 5 | 2019 | 31 | 0.180 |
Why?
|
| Muscle Contraction | 1 | 2021 | 284 | 0.180 |
Why?
|
| Exons | 2 | 2019 | 451 | 0.180 |
Why?
|
| Fibrosis | 5 | 2021 | 234 | 0.170 |
Why?
|
| Sarcoglycans | 2 | 2019 | 14 | 0.170 |
Why?
|
| Mice, Knockout | 4 | 2019 | 2001 | 0.170 |
Why?
|
| Gene Editing | 1 | 2019 | 48 | 0.170 |
Why?
|
| Myotonic Dystrophy | 1 | 2019 | 7 | 0.170 |
Why?
|
| MyoD Protein | 1 | 2019 | 16 | 0.170 |
Why?
|
| Heart Function Tests | 1 | 2019 | 33 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 5 | 2017 | 3218 | 0.160 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2020 | 280 | 0.160 |
Why?
|
| Ventricular Function | 1 | 2017 | 53 | 0.150 |
Why?
|
| Mice, Mutant Strains | 2 | 2016 | 231 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 1 | 2020 | 956 | 0.140 |
Why?
|
| Homozygote | 1 | 2017 | 204 | 0.140 |
Why?
|
| Female | 11 | 2024 | 46202 | 0.140 |
Why?
|
| Heart Conduction System | 1 | 2017 | 112 | 0.140 |
Why?
|
| Annexins | 1 | 2016 | 6 | 0.140 |
Why?
|
| Dystrophin-Associated Protein Complex | 1 | 2015 | 3 | 0.130 |
Why?
|
| Gene Expression Regulation | 4 | 2020 | 1976 | 0.130 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2015 | 68 | 0.130 |
Why?
|
| Cells, Cultured | 2 | 2017 | 2884 | 0.120 |
Why?
|
| Echocardiography | 2 | 2017 | 938 | 0.120 |
Why?
|
| Electrocardiography | 1 | 2017 | 494 | 0.120 |
Why?
|
| Heart Rate | 1 | 2017 | 495 | 0.120 |
Why?
|
| Adaptation, Physiological | 1 | 2017 | 314 | 0.120 |
Why?
|
| Systole | 1 | 2014 | 115 | 0.120 |
Why?
|
| Protein Engineering | 1 | 2015 | 141 | 0.120 |
Why?
|
| Pressure | 1 | 2014 | 165 | 0.120 |
Why?
|
| Constriction, Pathologic | 1 | 2014 | 217 | 0.110 |
Why?
|
| Immunoassay | 1 | 2013 | 91 | 0.110 |
Why?
|
| Aorta | 1 | 2014 | 288 | 0.110 |
Why?
|
| Actins | 1 | 2016 | 458 | 0.110 |
Why?
|
| Sequence Analysis, RNA | 1 | 2014 | 233 | 0.110 |
Why?
|
| Monocytes | 1 | 2014 | 218 | 0.110 |
Why?
|
| Genetic Therapy | 1 | 2015 | 370 | 0.110 |
Why?
|
| Oxidative Stress | 1 | 2015 | 458 | 0.100 |
Why?
|
| Heart | 2 | 2015 | 574 | 0.100 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 85 | 0.100 |
Why?
|
| Cardiomegaly | 1 | 2012 | 120 | 0.100 |
Why?
|
| Interleukin-10 | 1 | 2012 | 151 | 0.100 |
Why?
|
| Alleles | 1 | 2014 | 1135 | 0.090 |
Why?
|
| Serine | 1 | 2011 | 104 | 0.090 |
Why?
|
| Genotype | 1 | 2014 | 1849 | 0.080 |
Why?
|
| NF-kappa B | 1 | 2012 | 466 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 1431 | 0.080 |
Why?
|
| Receptors, Glucocorticoid | 2 | 2022 | 131 | 0.080 |
Why?
|
| Middle Aged | 4 | 2020 | 25974 | 0.070 |
Why?
|
| Protein Transport | 2 | 2016 | 421 | 0.060 |
Why?
|
| Bortezomib | 1 | 2024 | 82 | 0.060 |
Why?
|
| Gene Expression | 2 | 2019 | 1310 | 0.060 |
Why?
|
| Calmodulin | 1 | 2023 | 50 | 0.060 |
Why?
|
| Epinephrine | 1 | 2023 | 88 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2020 | 1862 | 0.050 |
Why?
|
| Models, Biological | 1 | 2009 | 1765 | 0.050 |
Why?
|
| Latent TGF-beta Binding Proteins | 1 | 2021 | 4 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2019 | 2017 | 0.050 |
Why?
|
| Kinetics | 2 | 2014 | 1528 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2012 | 1237 | 0.050 |
Why?
|
| Muscles | 1 | 2021 | 193 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 267 | 0.050 |
Why?
|
| Protein Domains | 1 | 2019 | 134 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2021 | 324 | 0.040 |
Why?
|
| Dystrophin | 1 | 2019 | 22 | 0.040 |
Why?
|
| Muscle Development | 1 | 2019 | 41 | 0.040 |
Why?
|
| Calcium Signaling | 1 | 2019 | 138 | 0.040 |
Why?
|
| Point Mutation | 1 | 2019 | 245 | 0.040 |
Why?
|
| Mole Rats | 1 | 2017 | 5 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 1012 | 0.040 |
Why?
|
| Rats | 3 | 2012 | 4041 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2019 | 152 | 0.040 |
Why?
|
| Mice, Inbred mdx | 1 | 2017 | 13 | 0.040 |
Why?
|
| Mice, Inbred DBA | 1 | 2017 | 149 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 105 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 308 | 0.040 |
Why?
|
| Muscular Atrophy | 1 | 2017 | 46 | 0.040 |
Why?
|
| Adult | 3 | 2024 | 26607 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 269 | 0.030 |
Why?
|
| Dialysis Solutions | 1 | 1995 | 7 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 6312 | 0.030 |
Why?
|
| Regeneration | 1 | 2017 | 150 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 294 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2016 | 136 | 0.030 |
Why?
|
| Malondialdehyde | 1 | 2015 | 26 | 0.030 |
Why?
|
| Protein Carbonylation | 1 | 2015 | 10 | 0.030 |
Why?
|
| Biomarkers | 2 | 2013 | 1767 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 1157 | 0.030 |
Why?
|
| Base Sequence | 1 | 2019 | 2327 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2016 | 273 | 0.030 |
Why?
|
| Transcriptome | 1 | 2020 | 630 | 0.030 |
Why?
|
| Peritoneal Dialysis | 1 | 1995 | 31 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2015 | 44 | 0.030 |
Why?
|
| Diaphragm | 1 | 2015 | 50 | 0.030 |
Why?
|
| Arginine | 1 | 1995 | 138 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 895 | 0.030 |
Why?
|
| Glutathione | 1 | 2015 | 108 | 0.030 |
Why?
|
| Adolescent | 2 | 2020 | 9263 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2015 | 82 | 0.030 |
Why?
|
| Renal Insufficiency | 1 | 1995 | 98 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2015 | 205 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 2496 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 1995 | 279 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2016 | 476 | 0.030 |
Why?
|
| Wound Healing | 1 | 2016 | 359 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 922 | 0.030 |
Why?
|
| Creatine Kinase, MB Form | 1 | 2013 | 7 | 0.030 |
Why?
|
| Electrochemical Techniques | 1 | 2013 | 8 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2015 | 565 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 740 | 0.030 |
Why?
|
| Troponin I | 1 | 2013 | 26 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2015 | 640 | 0.030 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2016 | 302 | 0.030 |
Why?
|
| Luminescent Measurements | 1 | 2013 | 62 | 0.030 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2015 | 317 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2014 | 253 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2014 | 501 | 0.030 |
Why?
|
| Myoblasts, Cardiac | 1 | 2012 | 3 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 1671 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 1995 | 645 | 0.030 |
Why?
|
| Isoproterenol | 1 | 2012 | 62 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2014 | 691 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2019 | 1374 | 0.030 |
Why?
|
| Ventricular Function, Left | 1 | 2016 | 605 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2012 | 200 | 0.020 |
Why?
|
| Binding Sites | 1 | 2014 | 1117 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2016 | 688 | 0.020 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2011 | 72 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 108 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2015 | 613 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 2015 | 509 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 338 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 1799 | 0.020 |
Why?
|
| Aged | 2 | 2020 | 19165 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 1714 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 2015 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2401 | 0.020 |
Why?
|
| Time Factors | 1 | 2011 | 5338 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2012 | 3385 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 6811 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1995 | 45 | 0.010 |
Why?
|
| Mesenteric Arteries | 1 | 1995 | 29 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1995 | 731 | 0.010 |
Why?
|